Journal of Clinical Endocrinology & Metabolism, Vol 81, 1224-1231, Copyright © 1996 by Endocrine Society

ARTICLES

Serum and follicular fluid levels of insulin-like growth factor I (IGF- I), IGF-II, and IGF-binding protein-1 and -3 during the normal menstrual cycle

HJ Thierry van Dessel, Y Chandrasekher, OW Yap, PD Lee, RL Hintz, GH Faessen, DD Braat, BC Fauser and LC Giudice
Department of Gynecology and Obstetrics, Stanford University Medical Center, California 94305-5317, USA.

Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) have important regulatory functions in ovarian follicular development. Although most studies have investigated the IGF system in ovarian cells in vitro, investigation of the IGF system in the peripheral circulation and in follicles of varying sizes throughout the menstrual cycle in large numbers of subjects has been lacking. In the current study we performed daily IGF-I, IGF-II, IGFBP-1, and IGFBP-3 measurements in 9 healthy regularly cycling volunteers throughout the menstrual cycle. In addition, we investigated IGF-I, IGF-II, IGFBP-1, and IGFBP-3 levels in 13 samples of androgen-dominant follicular fluid [FFa androstenedione to estradiol (AD:E2) ratio, > 4] and 19 samples of estrogen-dominant follicular fluid (FFe; AD:E2 ratio, 4) obtained from 21 regularly cycling subjects and in 18 samples of fluid from luteinizing follicles obtained from patients undergoing in vitro fertilization (IVF) treatment (FFivf). IGF-I, IGF-II, IGFBP-1, and IGFBP-3 were measured using two-site immunoradiometric assays. No significant day to day differences were observed in IGF-I, IGF-II, IGFBP-1, and IGFBP-3 levels across the menstrual cycle. Median IGF-II levels in FFe (630 ng/mL; range, 212-1000) were significantly higher compared to those in FFa (474 ng/mL; range, 272-603; P = 0.002). Median IGFBP-3 levels in FFe (2955 ng/mL; range, 388-3448) were also significantly higher than those in FFa (2352 ng/mL; range, 756-2604; P = 0.003). Median IGF-I (192 ng/mL; range, 29-256) and IGFBP-1 (12 ng/mL; range, 2-281) levels in FFe were not significantly different from those in FFa [149 (range, 22- 232) and 21 (range, 5-32) ng/mL, respectively). In contrast, significantly lower IGFBP-1 levels were found in FFe compared to FFivf (79 ng/mL; range, 57-234; P = 0.002), whereas there was no significant difference between FFe and FFivfe IGF-I, IGF-II, or IGFBP-3 levels, respectively. IGF-II levels were correlated with follicle diameter (r = 0.52; P = 0.002), cycle day (r = 0.47; P = 0.0065), E2 levels (r = 0.53; P = 0.003), AD:E2 ratio (r = -0.58; P = 0.001), and P concentrations (r = 0.60; P = 0.001) in all follicles, whereas no such correlations were found with IGF-I. In conclusion, as circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3 are not menstrual cycle dependent, it is unlikely that these growth factors and these binding proteins play an endocrine role in cyclic ovarian follicle development, although both cycle-dependent delivery to the ovary and modification of their actions locally within the ovary cannot be excluded. With regard to FF1 the findings that IGF-II levels in FF1 are elevated compared to those in FFa and correlate with follicular functional status support a role for IGF-II during development of the dominant follicle. In addition, as IGFBP-3 in estrogen-dominant follicles mirrors the rise of IGF-II, this IGFBP may be a primary regulator of IGF-II action within the estrogen-dominant follicle. Finally, the finding of elevated levels of IGFBP-1 in luteinizing (IVF) follicles suggests an important role for this peptide in corpus luteum regulation.

This article has been cited by other articles:

				L. Baglietto, D. R. English, J. L. Hopper, H. A. Morris, W. D. Tilley, and G. G. Giles Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and the Risk of Breast Cancer Cancer Epidemiol. Biomarkers Prev., April 1, 2007; 16(4): 763 - 768. [Abstract] [Full Text] [PDF]

				Y. S. Choi, S.-Y. Ku, B.-C. Jee, C.-S. Suh, Y. M. Choi, J. G. Kim, S. Y. Moon, and S. H. Kim Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients Hum. Reprod., August 1, 2006; 21(8): 2015 - 2021. [Abstract] [Full Text] [PDF]

				R. P A Rooman, L. O. De Beeck, M. Martin, J. van Doorn, S. Mohan, and M. V L Du Caju Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature Eur. J. Endocrinol., April 1, 2005; 152(4): 597 - 604. [Abstract] [Full Text] [PDF]

				E. S. Schernhammer, J. M. Holly, M. N. Pollak, and S. E. Hankinson Circulating Levels of Insulin-like Growth Factors, their Binding Proteins, and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 699 - 704. [Abstract] [Full Text] [PDF]

				N. D. Borofsky, J. H. Vogelman, R. A. Krajcik, and N. Orentreich Utility of Insulin-like Growth Factor-1 as a Biomarker in Epidemiologic Studies Clin. Chem., December 1, 2002; 48(12): 2248 - 2251. [Full Text] [PDF]

				E. Somigliana, P. Vigano, G.B. La Sala, M. Balasini, M. Candiani, L. Incerti, M. Busacca, and M. Vignali Follicular fluid as a favourable environment for endometrial and endometriotic cell growth in vitro Hum. Reprod., June 1, 2001; 16(6): 1076 - 1080. [Abstract] [Full Text] [PDF]

				H. Jernström, C. Deal, F. Wilkin, W. Chu, Y. Tao, N. Majeed, T. Hudson, S. A. Narod, and M. Pollak Genetic and Nongenetic Factors Associated with Variation of Plasma Levels of Insulin-like Growth Factor-I and Insulin-like Growth Factor-binding Protein-3 in Healthy Premenopausal Women Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 377 - 384. [Abstract] [Full Text]

				L. C. Giudice Insulin-like Growth Factor Family in Graafian Follicle Development and Function Reproductive Sciences, January 1, 2001; 8(1_suppl): S26 - S29. [Abstract] [PDF]

				N. A. Klein, D. E. Battaglia, T. K. Woodruff, V. Padmanabhan, L. C. Giudice, W. J. Bremner, and M. R. Soules Ovarian Follicular Concentrations of Activin, Follistatin, Inhibin, Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-2 (IGFBP-2), IGFBP-3, and Vascular Endothelial Growth Factor in Spontaneous Menstrual Cycles of Normal Women of Advanced Reproductive Age J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4520 - 4525. [Abstract] [Full Text]

				V. De Leo, A. la Marca, G. Morgante, L. Ciotta, L. Mencaglia, A. Cianci, and F. Petraglia Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome Hum. Reprod., November 1, 2000; 15(11): 2302 - 2305. [Abstract] [Full Text] [PDF]

				K. E. Wangen, A. M. Duncan, B. E. Merz-Demlow, X. Xu, R. Marcus, W. R. Phipps, and M. S. Kurzer Effects of Soy Isoflavones on Markers of Bone Turnover in Premenopausal and Postmenopausal Women J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3043 - 3048. [Abstract] [Full Text]

				A. Degeorges, F. Wang, H. F. Frierson , Jr., A. Seth, and R. A. Sikes Distribution of IGFBP-rP1 in Normal Human Tissues J. Histochem. Cytochem., June 1, 2000; 48(6): 747 - 754. [Abstract] [Full Text]

				B. Imani, M. J. C. Eijkemans, F. H. de Jong, N. N. Payne, P. Bouchard, L. C. Giudice, and B. C. J. M. Fauser Free Androgen Index and Leptin Are the Most Prominent Endocrine Predictors of Ovarian Response during Clomiphene Citrate Induction of Ovulation in Normogonadotropic Oligoamenorrheic Infertility J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 676 - 682. [Abstract] [Full Text]

				L. Devoto, L. K. Christenson, J. M. McAllister, A. Makrigiannakis, and J. F. Strauss III Insulin and insulin-like growth factor-I and- II modulate human granulosa-lutein cell steroidogenesis: enhancement of steroidogenic acute regulatory protein (StAR) expression Mol. Hum. Reprod., November 1, 1999; 5(11): 1003 - 1010. [Abstract] [Full Text] [PDF]

				H. J. H. M. T. van Dessel, P. D. K. Lee, G. Faessen, B. C. J. M. Fauser, and L. C. Giudice Elevated Serum Levels of Free Insulin-Like Growth Factor I in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3030 - 3035. [Abstract] [Full Text]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				R. Apa, F. Miceli, E. Pierro, F. Minici, P. Navarra, A. Caruso, M. Napolitano, S. Mancuso, and A. Lanzone Paracrine Regulation of Insulin-Like Growth Factor I (IGF-I) and IGF-II on Prostaglandins F2{alpha} and E2 Synthesis by Human Corpus Luteum in Vitro: A Possible Balance of Luteotropic and Luteolytic Effects J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2507 - 2512. [Abstract] [Full Text]

				A. Herrler, C. A. Krusche, and H. M. Beier Insulin and Insulin-like Growth Factor-I Promote Rabbit Blastocyst Development and Prevent Apoptosis Biol Reprod, December 1, 1998; 59(6): 1302 - 1310. [Abstract] [Full Text]

				P. Ovesen, N. Vahl, S. Fisker, J. D. Veldhuis, J. S. Christiansen, and J. O. L. Jørgensen Increased Pulsatile, But Not Basal, Growth Hormone Secretion Rates and Plasma Insulin-Like Growth Factor I Levels during the Periovulatory Interval in Normal Women J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1662 - 1667. [Abstract] [Full Text]

				I. Schipper, W. C. J. Hop, and B. C. J. M. Fauser The Follicle-Stimulating Hormone (FSH) Threshold/Window Concept Examined by Different Interventions with Exogenous FSH during the Follicular Phase of the Normal Menstrual Cycle: Duration, Rather Than Magnitude, of FSH Increase Affects Follicle Development J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1292 - 1298. [Abstract] [Full Text]

				S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text]

				W. Yuan and L. C. Giudice Programmed Cell Death in Human Ovary Is a Function of Follicle and Corpus Luteum Status J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3148 - 3155. [Abstract] [Full Text] [PDF]

				P. D. K. Lee, S. K. Durham, V. Martinez, O. Vasconez, D. R. Powell, and J. Guevara-Aguirre Kinetics of Insulin-Like Growth Factor (IGF) and IGF-Binding Protein Responses to a Single Dose of Growth Hormone J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2266 - 2274. [Abstract] [Full Text] [PDF]

				L. Putowski, R. M. Rohan, D. S. Choi, W. J. Scherzer, E. Ricciarelli, J. Mordacq, K. E. Mayo, and E. Y. Adashi Rat Ovarian Insulin-Like Growth Factor Binding Protein-4: A Hormone-Dependent Granulosa Cell-Derived Antigonadotropin Reproductive Sciences, May 1, 1997; 4(3): 144 - 151. [Abstract] [PDF]

				I. Schipper, F. F. G. Rommerts, P. M. ten Hacken, and B. C. J. M. Fauser Low Levels of Follicle-Stimulating Hormone Receptor-Activation Inhibitors in Serum and Follicular Fluid from Normal Controls and Anovulatory Patients with or without Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 1997; 82(5): 1325 - 1331. [Abstract] [Full Text] [PDF]

				B. C. J. M. Fauser and A. M. van Heusden Manipulation of Human Ovarian Function: Physiological Concepts and Clinical Consequences Endocr. Rev., February 1, 1997; 18(1): 71 - 106. [Abstract] [Full Text]